Long Noncoding RNAs in the Pathogenesis of Insulin Resistance

Area of Science:

• Molecular Biology
• Metabolic Diseases
• Genetics

Background:

• Insulin resistance (IR) is a critical factor in developing diabetes and nonalcoholic fatty liver disease (NAFLD).
• The precise mechanisms underlying IR require further investigation.
• Long non-coding RNAs (lncRNAs) are emerging as significant regulators of cellular processes and metabolic diseases.

Purpose of the Study:

• To review the current understanding of lncRNAs' roles in the pathogenesis of insulin resistance.
• To discuss the mechanisms by which lncRNAs influence insulin signaling and metabolism.
• To highlight the involvement of lncRNAs in key metabolic tissues like the liver, skeletal muscle, and adipose tissue.

Main Methods:

• Literature review of recent research on lncRNAs and insulin resistance.
• Analysis of studies investigating lncRNA expression profiles in metabolic diseases.
• Synthesis of data on specific lncRNAs (e.g., MEG3, H19, MALAT1, GAS5, lncSHGL) and their functions.

Main Results:

• Evidence indicates that lncRNAs are involved in the development and progression of insulin resistance.
• Dysregulated lncRNA profiles are associated with metabolic disorders such as obesity, diabetes, and NAFLD.
• Specific lncRNAs have been identified to regulate insulin signaling pathways and glucose/lipid metabolism.

Conclusions:

• lncRNAs represent a novel class of molecules implicated in the pathophysiology of insulin resistance.
• Understanding lncRNA functions offers potential therapeutic targets for metabolic diseases.
• Further research into lncRNA mechanisms is crucial for developing effective treatments for IR-related conditions.